Schonfeld Strategic Advisors’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-40,649
Closed -$170K 2416
2025
Q1
$170K Buy
+40,649
New +$185K ﹤0.01% 1961
2024
Q4
Sell
-90,500
Closed -$333K 2293
2024
Q3
$333K Sell
90,500
-14,400
-14% -$51K ﹤0.01% 1610
2024
Q2
$425K Buy
104,900
+45,300
+76% +$193K ﹤0.01% 1560
2024
Q1
$285K Buy
59,600
+13,600
+30% +$79.1K ﹤0.01% 1667
2023
Q4
$348K Sell
46,000
-8,900
-16% -$73.1K ﹤0.01% 1393
2023
Q3
$563K Buy
54,900
+9,331
+20% +$115K ﹤0.01% 1176
2023
Q2
$628K Buy
+45,569
New +$684K 0.01% 1131
2022
Q4
Sell
-14,500
Closed -$283K 2905
2022
Q3
$283K Sell
14,500
-2,924
-17% -$62.1K ﹤0.01% 2123
2022
Q2
$346K Buy
+17,424
New +$389K ﹤0.01% 1577
2021
Q3
Sell
-6,896
Closed -$219K 2391
2021
Q2
$219K Buy
+6,896
New +$219K ﹤0.01% 1626
2020
Q2
Sell
-8,600
Closed -$248K 1488
2020
Q1
$248K Sell
8,600
-5,700
-40% -$149K 0.02% 828
2019
Q4
$337K Buy
+14,300
New +$320K 0.01% 914

Other funds holding PETS

Schonfeld Strategic Advisors's PETS Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of PetMed Express (PETS) in Q2 2025, closing a stake of 40,649 shares — an estimated $170K sold.

Schonfeld Strategic Advisors first reported a position in PETS in Q4 2019 and held it in 12 quarters. The position peaked at $628K in Q2 2023. 64 funds tracked by Wall St. Rank hold PETS as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining PetMed Express position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 40,649 PetMed Express shares in Q2 2025, an estimated $170K.
  • Schonfeld Strategic Advisors first reported a position in PetMed Express in Q4 2019 and held it in 12 quarters.
  • Schonfeld Strategic Advisors's PetMed Express position peaked at $628K in Q2 2023.
  • 64 funds tracked by Wall St. Rank held PetMed Express as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.